Early Results of the Heart Transplantation for End Stage Heart Failure

말기 심부전증 환자에 대한 심장이식술의 조기 성적

  • 노준량 (서울대학교병원 흉부외과, 서울대학교 의부학과 흉부외과학교실) ;
  • 원태희 (서울대학교병원 흉부외과, 서울대학교 의부학과 흉부외과학교실, 이화여자대하ㄱ 의과대학부속 동대문병원 흉부외과)
  • Published : 1997.09.01

Abstract

Fourteen patients underwent orthotopic heart transplantation between March 1994 and May 1996 in Seoul National University Hospital. There were 9 male and 5 female patients, and the mean age was 40.8 $\pm$ 12.4 years ranged from 12 to 56 years. All patient were in NYHA Fc III or IV preoperatively. The underlying heart diseases were dilated cardiomyopathy in 11 and restrictive cardiomyopathy in 3. The mean age of donors was 24.9$\pm$ 10.2 years and the causes of the brain death were head trauma by traffic accidents in 8, subarachnoid hemorrhage in 2, 1 asphyxia, 1 fall down injury, 1 brain tumo , and 1 drowning, respectively The blood type was identical in 11, compatible in 2, and incompatible in 1 patient. The direct bicaval anastomosis technique was used in 11 cases, and standard right atrial anastomosis was done in the remaining 3 cases. The graft ischemic time was 158$\pm$44 minutes ranged 94 to 220 minutes. There were two hospital deaths(14.3%). The causes of deaths were 1 right ventricular failure followed by suspected cyclosporine induced hemolytic uremic syndrome and rejection, and 1 delayed massive bleeding, probably from rupture of the anastomotic pseudoaneurysm, respectively. The follow-up duration was 16$\pm$9 months(3 to 28 months). There was one late death(8.3%). All the other patients were in NYHA Fc I except one patient who was in hospital because of the acute rejection. The actuarial survival rates including hospital deaths were 93.7% at 1 month, 86.9% at 6 months, and 77$\pm$12% at 2 years. Conclusively, heart transplantation is the good strategy for the management of end stage heart disease with acceptable operative mortality and early follow-up results.

서울대학교병원 흉부외과에서는 1994년 3월부터 1996년 5월까지 14명의 환자에 있어서 심장이식술을 시행 하였다. 남자가 9명 여자가 5명이었으며 평균나이는 40.8 $\pm$ 12.4세 이었다. 수술전 모든 환자들은 UiID Fc III 또는 IV이었으며 술전 진단은 확장성 심근병증이 11명, 제한성 심근병증이 3명이었다. 장기 공여자의 평균연령은 24.9 $\pm$ 10.2세 이었으며 뇌사의 원인으로는 교통사고에 의한 뇌손상이 8명으로 가장 많았으며 거미막하 출혈이 2명, 이 물질에 의한 기도폐쇄, 추락사고, 뇌종양, 익사사고 등이 각각 1명이 었다. 수혜자와 공여자의 혈액형은 11명에 있어서는 일치되었고 2명에 있어서는 적합하였으나 1명의 환자에 있 어서는 부적합하였다. 11명의 환자에 있어서는 양대정맥을 직접 문합하는 방법을 사용하였으며 3명의 환자에 있어서는 우심방을 연결하는 방법을 사용하였으며 평균 이식심장 허혈시간은 157.8 $\pm$ 43.8분(94-220분) 이었다. 2명이 사망하 여 병원 사망률은 14.3%이었다. 사망원인은 우심실부전, 사이클로스포린 유발성 용혈성요독증후군, 거부반응 으로 인한 다발성 장기부전과 대동맥 문합부위 가성동맥류의 파열로 의심되는 酉\ulcorner銖汰潔駭\ulcorner 평균추적기간은 16.2 $\pm$ 9.0개월(3-28개월) 이었으며 만기사망은 1례 있었다. (8.3%) 마지막 추적당시 급성 거부반응으로 치료를 받고 있는 1명을 제외한 모든 환자들은 UnD Fc I이었다. 병원사망을 포함한 1개월 및 6개월, 2년 생존율은 각각 n.9 $\pm$ 6.9%, 85.7 $\pm$ 9.4% , 77.1 $\pm$ 11.7% 이었다. 결론적으로 심장이식술은 말기 심부전환자의 이상적인 치료법이며 앞으로 장기적인 추적검사가 필요하리라 생각된다.

Keywords

References

  1. S Afr Med J v.41 A human cardiac transplant: An interim report of a successful operation performed at Groote Schur Hospital Barnard CN
  2. J Heart Lung Transplant v.13 The registry of the international society for the heart and lung transplantation : Eleventh official report-1994 Hosenpud JD;Novick RJ;Breen TJ;Daily OP
  3. 순환기 v.25 no.3 Heart Transplantation : 초기 성적 및 2년 생존 김재중;송명근;서동만(등)
  4. 대흉외지 v.29 ABO 부적합성 심장이식술 원태희;신윤철;김기봉;김용진;노준량
  5. 대흉외지 v.29 심장이식환자의 임상적 고찰 박국양;박철현;김욱성(등)
  6. Surg Forum v.11 Studies on orthotopic transplantation of the canine heart Lower RR;Shumway NE
  7. J Heart Transplant v.3 Heart and heart lung transplantation:techniques and safe guards Carbrol C;Gandjbakch I;Pavie A(et al.)
  8. J Thorac Cardiovasc Surg v.109 Orthotopic cardiac transplantation with direct caval anastomosis: Is it the optimal procedure? Deleuze PH;Benvenuti C;Mazzucotelli JP(et al.)
  9. J Thorac Cardiovasc Surg v.109 Orthotopic cardiac transplantation: a comparison of standard and bicaval wythenshawe techniques Gamel AE;Yonan NA;Grant S(et al.)
  10. Ann Thorac Surg v.52 Total orthotopic heart transplantation: An alternative to the standard technique Dreyfus G;Jebara V;Milhaileanu S;Carpentier AF
  11. Circulation v.66 Prevalence and significance of arrhythmials in long term survivors of cardiac transplantation Romhilt DW;Doyle M;Sagar KB(et al.)
  12. J Heart Transplant v.7 Pacemaker implantation in patients after cardiac transplantation(abstract) Grusk BB;Grady KL
  13. Ann Thorac Surg v.59 Determinants of hospital survival after cardiac transplantation Ibrahim M;Masters RG;Hendry PJ(et al.)
  14. J Heart Lung Transplant v.12 Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study Bourge RC;Naftel DC;Costanzo-Nordin MR(et al.)
  15. Ann Thorac Surg v.45 Cardiac transplantation in patients over 60 years of age Frazier OH;Marcis MP;Duncan MJ;Van Buren CT;Cooley DA
  16. Transplant Proc v.24 Variables affecting clinical results aft er heart transplantation using older donors Luciani GB;Faggian G;Livi U;Mazzucco A
  17. J Heart Lung Transplant v.11 A Clinical results of heart transplantation in recipients over 55 years of age with donors over 40 years of age Luciani BB;Livi U;Faggian G;Mazzucco A
  18. Circulation v.80 no.suppl.3 Cardiac allograft ischemic time: relation to graft survival and cardiac function Pflugfelder PW;Thomson D;Singh NR;Menkis AH;McKenzie FN;Kostuk WJ
  19. Circulation v.86 Cardiac transplantation:recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the committee on cardiac transplantation of the council on clinical cardiology, American Heart Association O'Connell JB;Bourge RC;Costanzo-Nordin MR(et al.)
  20. Circulation v.94 Influence of HLA matching on thoracic transplant outcomes- An analysis from the UNOS/ISHLT thoracic registry Hosenpud JD;Edwards EB;Lin HM;Daily OP